(TNXP) - Analyzing Tonix Pharmaceuticals's Short Interest

Benzinga14:30 ET

Express News | Tonix Pharmaceuticals Holding Corp - Expects Topline Data for Tnx-1300 in Q3 2025, Tnx-1500 in Q1 2025

ReutersJan 8 07:40 ET

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team With Appointment of Gary Ainsworth as Vice President of Market Access

GlobeNewswireJan 8 07:00 ET

Tonix Pharmaceuticals Achieves Key Milestone With FDA Review Timeline for Innovative Fibromyalgia Treatment | NASDAQ:TNXP

Proactive InvestorsDec 24, 2024 08:44 ET

Trending Stocks Today | Nocera Surges 63.95% Post-Market

Moomoo NewsDec 23, 2024 18:00 ET

Tonix Pharmaceuticals Announces PDUFA Goal Date Of August 15, 2025, For FDA Decision On U.S. Marketing Approval For TNX-102 SL For Fibromyalgia

BenzingaDec 23, 2024 08:08 ET